You are here

  • Home
  • Archive
  • Volume 12, Issue 11
  • Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment

Article info

Article menu

Download PDFPDF

XML
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Case report
Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment

Authors

  • Tatsuya Ibe Department of Pulmonary Medicine, National Hospital Organization Nishisaitama-Chuo National Hospital, Tokorozawa, Japan PubMed articlesGoogle scholar articles
  • Yoichiro Hamamoto Department of Pulmonary Medicine, National Hospital Organization Nishisaitama-Chuo National Hospital, Tokorozawa, Japan PubMed articlesGoogle scholar articles
  • Mikage Takabatake Laboratory of Pathology, Department of Medical Biophysics, Kobe University Faculty of Health Sciences and Graduate School of Medicine Faculty of Health Sciences, Kobe, Hyogo, Japan PubMed articlesGoogle scholar articles
  • Shingo Kamoshida Laboratory of Pathology, Department of Medical Biophysics, Kobe University Faculty of Health Sciences and Graduate School of Medicine Faculty of Health Sciences, Kobe, Hyogo, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yoichiro Hamamoto; hamamoto32{at}gmail.com
View Full Text

Citation

Ibe T, Hamamoto Y, Takabatake M, et al
Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment
BMJ Case Reports CP 2019;12:e231464.

Publication history

  • Accepted November 15, 2019
  • First published November 26, 2019.
Online issue publication 
April 27, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.